Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.
Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results